Cardio-metabolic Dialogues 2

Thu 08 November 2018

Translation & Innovation Hub
Imperial College London
White City Campus
80 Wood Lane
London W12 0BZ

Conference Collective Ltd

Who should attend?

The content is aimed at Consultants, Specialist Registrars or equivalent, who are concerned with T2DM, renal medicine and cardiology, as well as General Practitioners with an interest in these areas.

Why attend?

The meeting will be held at Imperial College London’s Translation and Innovation Hub on Thursday 8 November 2018, and will explore the latest concepts, techniques and developments in cardio-metabolic science. Invited faculty will deliver this innovative, intense, educational programme, covering the emerging association between diabetes, heart attacks, renal events and stroke. The programme includes a mix of presentations to discuss how the data and topics covered can be implemented into everyday practice.

What will I learn?

By attending this one-day meeting you will acquire new knowledge and understanding about:

• The relationship between diabetes and heart attacks and strokes, pathophysiology and epidemiology

• The emerging association between diabetes and heart failure including the burden of disease, epidemiology and pathophysiology

• The role of glycaemic control, lipid lowering and blood pressure control in the prevention of cardiovascular disease among those with diabetes

• The benefits of novel therapies on glycaemic control and cardiovascular outcomes focusing on GLP-1 agonists and SGLT2 inhibitors

• The pathophysiology of renal complications in diabetes and therapies that reduce these complications

• The relationship between severe daytime & nocturnal hypoglycaemic episode, CV events, mortality and the frail patient

• The logistical requirements to improve patient exposure to best diabetes care after a major CV event

• The latest data guiding optimal lipid and hypertension management for patients with CKD, T2DM and treatment following a cardiovascular event.